
A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.
QH301-705.5, Science, Q, R, Antineoplastic Agents, leukemic stem cell, CITE-Seq, Drug Resistance, Neoplasm, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplastic Stem Cells, cancer, Medicine, Humans, Biology (General), CML, CD35, CD26, Cancer Biology
QH301-705.5, Science, Q, R, Antineoplastic Agents, leukemic stem cell, CITE-Seq, Drug Resistance, Neoplasm, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplastic Stem Cells, cancer, Medicine, Humans, Biology (General), CML, CD35, CD26, Cancer Biology
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
